✦ LIBER ✦

Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors

✍ Scribed by Kushner, Brian H. ;Kramer, Kim ;Meyers, Paul A. ;Wollner, Norma ;Cheung, Nai-Kong V.

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 109 KB
Volume: 35
Category: Article
ISSN: 0098-1532
DOI: 10.1002/1096-911x(20001101)35:5<468::aid-mpo5>3.0.co;2-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose rate intraoperative radiation

High-dose rate intraoperative radiation therapy for pediatric solid tumors

✍ Merchant, Thomas E.; Zelefsky, Michael J.; Sheldon, John M.; LaQuaglia, Michael 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 1 views

Background. Sixteen pediatric patients with solid tumors received treatment on a protocol designed to test the feasibility and safety of high-dose rate intraoperative radiation therapy (IOHDR) via a remote afterloader. Patients and Methods. Patients with Ewing's sarcoma (n = 5), rhabdomyosarcoma (n

Phase I topotecan preparative regimen fo

Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors

✍ Park, Julie R. ;Slattery, John ;Gooley, Theodore ;Hawkins, Douglas ;Lindsley, Ka 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Toxicity of high-dose cytosine arabinosi

Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy a pediatric oncology group study

✍ Cameron K. Tebbi; Jeffrey Krischer; Donald J. Fernbach; Donald H. Mahoney; Carlo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 2 views

Phase I study of high-dose thiotepa with

Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors

✍ Pession, Andrea; Prete, Arcangelo; Locatelli, Franco; Bella, Santiago; Melchiond 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Background. The aim of this phase I study was to define the maximum tolerated dose (MTD) of thiotepa (TT), administered with busulfan (BU) 480 mg/m 2 and etoposide 2,400 mg/m 2 , followed by autologous bone marrow transplantation (ABMT) or peripheral blood stem cell transplantation (APBSCT) support

A combination chemotherapy with low dose

A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage: A pilot study

✍ Shin-ichiro Kuriya; Kazunori Murai; Yasuro Miyairi; Taiju Utsugisawa; Yasushi Na 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

## BACKGROUND. Even now, no definitely effective therapy is inducted to high risk myelodysplastic syndromes (MDS) and their leukemic stage (MDS-AML) except bone marrow transplantation. ## METHODS. Ten patients with high risk MDS and 6 with MDS-AML were treated with daily low doses of cytarabine

A dose-intensive, cyclophosphamide-based

A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/Progressive or advanced solid tumors of childhood : A report from the Australia and New Zealand Children's Cancer Study Group

✍ Paul A. Carpenter; Les White; Geoffrey B. McCowage; Vimala Nayanar; Ian Toogood; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.